-
1
-
-
0032965572
-
Role of iron in anthracycline cardiotoxity: New tunes for an old song?
-
Minotti, G.; Cairo, G.; Monti, E. Role of iron in anthracycline cardiotoxity: new tunes for an old song? FASEB J. 1999, 13, 199-212.
-
(1999)
FASEB J.
, vol.13
, pp. 199-212
-
-
Minotti, G.1
Cairo, G.2
Monti, E.3
-
3
-
-
0036597092
-
Tumor immunology and the battle of Waterloo
-
Acres, B.; Beverley, P.; Scholl, S. Tumor immunology and the battle of Waterloo. Mol. Cancer. Ther. 2002, 1, 651-655.
-
(2002)
Mol. Cancer. Ther.
, vol.1
, pp. 651-655
-
-
Acres, B.1
Beverley, P.2
Scholl, S.3
-
4
-
-
85013312416
-
Tumor angiogenesis: Therapeutic implications
-
Folkman, J. Tumor angiogenesis: therapeutic implications. N. Eng. J. Med. 1971, 285, 1182-1186.
-
(1971)
N. Eng. J. Med.
, vol.285
, pp. 1182-1186
-
-
Folkman, J.1
-
6
-
-
0033840389
-
Vasculogenic mimicry and tumor angiogenesis
-
Folberg, R.; Hendrix, M. J. C.; Maniotis, A. J. Vasculogenic mimicry and tumor angiogenesis. J. Pathol. 2000, 156, 361-381.
-
(2000)
J. Pathol.
, vol.156
, pp. 361-381
-
-
Folberg, R.1
Hendrix, M.J.C.2
Maniotis, A.J.3
-
7
-
-
0036467568
-
Rational therapeutic intervention in cancer: Kinases as drug targets
-
Sawyers, C. L. Rational therapeutic intervention in cancer: kinases as drug targets. Curr. Op. Genet, Dev. 2002, 12, 111-115.
-
(2002)
Curr. Op. Genet. Dev.
, vol.12
, pp. 111-115
-
-
Sawyers, C.L.1
-
8
-
-
0036304331
-
The mutator phenotype theory can explain the complex morphology and behaviour of cancers
-
Bignold, L. P. The mutator phenotype theory can explain the complex morphology and behaviour of cancers. Cell Mol. Life Sci. 2002, 59, 950-958.
-
(2002)
Cell Mol. Life Sci.
, vol.59
, pp. 950-958
-
-
Bignold, L.P.1
-
9
-
-
0035800507
-
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
-
Gorre, M. E.; Mohammed, M.; Ellwood, K.; Hsu, N.; Paquette, R. et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001, 293, 876-880.
-
(2001)
Science
, vol.293
, pp. 876-880
-
-
Gorre, M.E.1
Mohammed, M.2
Ellwood, K.3
Hsu, N.4
Paquette, R.5
-
10
-
-
0015428317
-
Antitumor and antileukemic effects of some steroids and other biologically interesting compounds containing an alkylating agent
-
Carroll, F. I.; Philip, A.; Blackwell, J. T.; Taylor, D. J.; Wall, W. E. Antitumor and antileukemic effects of some steroids and other biologically interesting compounds containing an alkylating agent. J. Med. Chem. 1972, 15, 1158-1161.
-
(1972)
J. Med. Chem.
, vol.15
, pp. 1158-1161
-
-
Carroll, F.I.1
Philip, A.2
Blackwell, J.T.3
Taylor, D.J.4
Wall, W.E.5
-
11
-
-
0033152091
-
Preclinical activity of 17β-[N-[N′-(2-chloroethyl)-N′ -nitrosocarbamoyl]-L-alanyl]-5α-dihydrotestosterone (E91) against tumour colony forming units and haematopoietic progenitor cells
-
Rank, P.; Peter, R.; Depenbrock, H.; Eisenbrand, G.; Schmid, P. et al. Preclinical activity of 17β-[N-[N′-(2-chloroethyl)-N′ -nitrosocarbamoyl]-L-alanyl]-5α-dihydrotestosterone (E91) against tumour colony forming units and haematopoietic progenitor cells. Eur. J. Cancer. 1999, 35, 1009-1013.
-
(1999)
Eur. J. Cancer.
, vol.35
, pp. 1009-1013
-
-
Rank, P.1
Peter, R.2
Depenbrock, H.3
Eisenbrand, G.4
Schmid, P.5
-
12
-
-
0028101210
-
Chemosensitivity of human breast carcinoma cell lines to 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl) urea linked to 4-acetoxybisdesmethyltamoxifen, estradiol or dihydrotestosterone
-
Kaleagasioglu, F.; Berger, M. R.; Schmähl, D.; Eisenbrand, G. Chemosensitivity of human breast carcinoma cell lines to 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl) urea linked to 4-acetoxybisdesmethyltamoxifen, estradiol or dihydrotestosterone. Tr. J. Med. Sci. 1994, 21.
-
(1994)
Tr. J. Med. Sci.
, pp. 21
-
-
Kaleagasioglu, F.1
Berger, M.R.2
Schmähl, D.3
Eisenbrand, G.4
-
13
-
-
0035950067
-
N-Succinyl-(β-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin: An extracellularly tumor-activated prodrug devoid of intervenous acute toxicity
-
Fernandez, A.; Van derpoorten, K.; Dasnois, L.; Lebtahi, K.; Dubois, V. et al. N-Succinyl-(β-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin: an extracellularly tumor-activated prodrug devoid of intervenous acute toxicity. J. Med. Chem. 2001, 44, 3750-3753.
-
(2001)
J. Med. Chem.
, vol.44
, pp. 3750-3753
-
-
Fernandez, A.1
Van Derpoorten, K.2
Dasnois, L.3
Lebtahi, K.4
Dubois, V.5
-
14
-
-
0031030324
-
Design, synthesis, and in vitro evaluation of cytotoxic analogues of bombesin-like petides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin
-
Nagy, A.; Armatis, P.; Cai, R.; Szepeshazi, K.; Halmos, G. et al. Design, synthesis, and in vitro evaluation of cytotoxic analogues of bombesin-like petides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 652-656.
-
(1997)
Proc. Natl. Acad. Sci. U.S.A.
, vol.94
, pp. 652-656
-
-
Nagy, A.1
Armatis, P.2
Cai, R.3
Szepeshazi, K.4
Halmos, G.5
-
15
-
-
0036725452
-
Design, synthesis, and biological evaluation of a dual tumor-specific motive containing integrin-targeted plasmin-cleavable doxorubicin prodrug
-
de Groot, F. M. H.; Broxterman, H. J.; Adams, H. P. H. M.; van Vliet, A. ; Tesser, G. I. et al. Design, synthesis, and biological evaluation of a dual tumor-specific motive containing integrin-targeted plasmin-cleavable doxorubicin prodrug. Mol. Cancer Ther. 2002, 1, 901-911.
-
(2002)
Mol. Cancer Ther.
, vol.1
, pp. 901-911
-
-
De Groot, F.M.H.1
Broxterman, H.J.2
Adams, H.P.H.M.3
Van Vliet, A.4
Tesser, G.I.5
-
16
-
-
0035862692
-
Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity
-
Guillemard, V.; Saragovi, H. U. Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity. Cancer Res. 2001, 61, 694-699.
-
(2001)
Cancer Res.
, vol.61
, pp. 694-699
-
-
Guillemard, V.1
Saragovi, H.U.2
-
17
-
-
0035816158
-
Tumor targeting by conjugation of DHA to paclitaxel
-
Bradley, M. O.; Swindell, C. S.; Anthony, A. C.; Donehower, R. C. Tumor targeting by conjugation of DHA to paclitaxel. J. Controlled Release 2001, 74, 233-236.
-
(2001)
J. Controlled Release
, vol.74
, pp. 233-236
-
-
Bradley, M.O.1
Swindell, C.S.2
Anthony, A.C.3
Donehower, R.C.4
-
18
-
-
0030665660
-
Biological properties of conjugates of mitomycin C with estradiol benzoate and estradiol: Their stability characteristics in biological media and their binding abilities to estrogen receptor
-
Ishiki, N.; Onishi, H.; Machida, Y. Biological properties of conjugates of mitomycin C with estradiol benzoate and estradiol: their stability characteristics in biological media and their binding abilities to estrogen receptor. Biol. Pharm. Bull. 1997, 20, 1096-1102.
-
(1997)
Biol. Pharm. Bull.
, vol.20
, pp. 1096-1102
-
-
Ishiki, N.1
Onishi, H.2
Machida, Y.3
-
19
-
-
0032819838
-
Anti-cancer activity of targeted pro-apoptotic peptides
-
Ellerby, H. M.; Arap, W.; Ellerby, L. M.; Kain, R.; Andrusiak, R. et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat. Med. 1999, 5, 1032-1038.
-
(1999)
Nat. Med.
, vol.5
, pp. 1032-1038
-
-
Ellerby, H.M.1
Arap, W.2
Ellerby, L.M.3
Kain, R.4
Andrusiak, R.5
-
20
-
-
0034608532
-
Synthesis and evaluation of geldanamycin-testosterone hybrids
-
Kuduk, S. D.; Harris, C. R.; Zheng, F. F.; Sepp-Lorenzino, L.; Ouerfelli, Q. et al. Synthesis and evaluation of geldanamycin-testosterone hybrids. Bioorg. Med. Chem. Lett. 2000, 10, 1303-1306.
-
(2000)
Bioorg. Med. Chem. Lett.
, vol.10
, pp. 1303-1306
-
-
Kuduk, S.D.1
Harris, C.R.2
Zheng, F.F.3
Sepp-Lorenzino, L.4
Ouerfelli, Q.5
-
21
-
-
0034880150
-
Gemtuzumab ozogamicin
-
McGavin, J. K.; Spencer, C. M. Gemtuzumab ozogamicin. Drugs 2001, 61, 1317-1322.
-
(2001)
Drugs
, vol.61
, pp. 1317-1322
-
-
McGavin, J.K.1
Spencer, C.M.2
-
22
-
-
0035328474
-
Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer
-
Linja, M. J.; Savinainen, K. J.; Saramäki, O. R.; Tammela, T. L. J. ; Vessella, R. L. et al. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res. 2001, 61, 3550-3555.
-
(2001)
Cancer Res.
, vol.61
, pp. 3550-3555
-
-
Linja, M.J.1
Savinainen, K.J.2
Saramäki, O.R.3
Tammela, T.L.J.4
Vessella, R.L.5
-
23
-
-
0030737770
-
Doxoform and Daunoform: Anthracycline-Formaldehyde Conjugates Toxic to Resistant Tumor Cells
-
Fenick, D. J.; Taatjes, D. J.; Koch, T. H. Doxoform and Daunoform: Anthracycline-Formaldehyde Conjugates Toxic to Resistant Tumor Cells. J. Med. Chem. 1997, 40, 2452-2461.
-
(1997)
J. Med. Chem.
, vol.40
, pp. 2452-2461
-
-
Fenick, D.J.1
Taatjes, D.J.2
Koch, T.H.3
-
24
-
-
0036043551
-
Evaluation of the epidoxorubicin-formaldehyde conjugate, epidoxoform, in a mouse mammary carcinoma model
-
Dernell, W. S.; Powers, B. E.; Taatjes, D. J.; Cogan, P.; Gaudiano, G. et al. Evaluation of the epidoxorubicin-formaldehyde conjugate, epidoxoform, in a mouse mammary carcinoma model. Cancer Invest. 2002, 20, 712-723.
-
(2002)
Cancer Invest.
, vol.20
, pp. 712-723
-
-
Dernell, W.S.1
Powers, B.E.2
Taatjes, D.J.3
Cogan, P.4
Gaudiano, G.5
-
25
-
-
0035890824
-
Molecular basis for the synergistic interaction of adriamycin with the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate (AN-9)
-
Cutts, S. M.; Rephaeli, A.; Nudelman, A.; Hmelnitsky, I.; Phillips, D. R. Molecular basis for the synergistic interaction of adriamycin with the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate (AN-9). Cancer Res. 2001, 61, 8194-8202.
-
(2001)
Cancer Res.
, vol.61
, pp. 8194-8202
-
-
Cutts, S.M.1
Rephaeli, A.2
Nudelman, A.3
Hmelnitsky, I.4
Phillips, D.R.5
-
27
-
-
0034103982
-
Androgens and androgen receptor: Do they play a role in breast cancer?
-
Brys, M. Androgens and androgen receptor: do they play a role in breast cancer? Med. Sci. Monit. 2000, 6, 433-438.
-
(2000)
Med. Sci. Monit.
, vol.6
, pp. 433-438
-
-
Brys, M.1
-
28
-
-
0031846672
-
Prostate-specific antigen and gross cystic disease fluid protein-15 are coexpressed in androgen receptor-positive breast tumors
-
Hall, R.; Clements, J.; Birrell, S.; Tilley, W. Prostate-specific antigen and gross cystic disease fluid protein-15 are coexpressed in androgen receptor-positive breast tumors. Br. J. Cancer. 1998, 78, 360-365.
-
(1998)
Br. J. Cancer
, vol.78
, pp. 360-365
-
-
Hall, R.1
Clements, J.2
Birrell, S.3
Tilley, W.4
-
29
-
-
0034093595
-
Androgen receptor gene mutations do not occur in ovarian cancer
-
Engehausen, D. G.; Tong, X.; Oehler, M. K.; Freund, C. T.; Schrott, K. M. et al. Androgen receptor gene mutations do not occur in ovarian cancer. Anticancer Res. 2000, 20, 815-819.
-
(2000)
Anticancer Res.
, vol.20
, pp. 815-819
-
-
Engehausen, D.G.1
Tong, X.2
Oehler, M.K.3
Freund, C.T.4
Schrott, K.M.5
-
30
-
-
0035169866
-
Evidience of androgen receptor expression in squamous and adenocarcinoma of the esophagus
-
Tihan, T.; Harmon, J. W.; Wan, X.; Younes, Z.; Nass, P. et al. Evidience of androgen receptor expression in squamous and adenocarcinoma of the esophagus. Anticancer Res. 2001, 21, 3107-3114.
-
(2001)
Anticancer Res.
, vol.21
, pp. 3107-3114
-
-
Tihan, T.1
Harmon, J.W.2
Wan, X.3
Younes, Z.4
Nass, P.5
-
31
-
-
9444229891
-
Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer
-
Kaiser, U.; Hofmann, J.; Schilli, M.; Wegmann, B.; Klotz, U. et al. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int. J. Cancer. 1996, 67, 357-364.
-
(1996)
Int. J. Cancer
, vol.67
, pp. 357-364
-
-
Kaiser, U.1
Hofmann, J.2
Schilli, M.3
Wegmann, B.4
Klotz, U.5
-
32
-
-
0037085420
-
Androgen receptor expression and DNA content of paraffin-Embedded archival human prostate tumors
-
Adiga, S. K.; Andritsch, I.; Rao, R. V.; Krishan, A. Androgen receptor expression and DNA content of paraffin-Embedded archival human prostate tumors. Cytometry 2002, 50, 25-30.
-
(2002)
Cytometry
, vol.50
, pp. 25-30
-
-
Adiga, S.K.1
Andritsch, I.2
Rao, R.V.3
Krishan, A.4
-
33
-
-
0030948745
-
Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor
-
Georget, V.; Lobaccaro, J. M.; Terouanne, B.; Mangeat, p.; Nicolas, J. et al. Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor. Mol. Cell Endocrinol, 1997, 129, 17-26.
-
(1997)
Mol. Cell Endocrinol.
, vol.129
, pp. 17-26
-
-
Georget, V.1
Lobaccaro, J.M.2
Terouanne, B.3
Mangeat, P.4
Nicolas, J.5
-
34
-
-
0026591729
-
Anti-androgens and the mutated androgen receptor of LNCaP cells: Differential effects on binding affinity, heat-shock protein interaction, and transcription activation
-
Veldscholte, J.; Brinkman, A. O.; Grootegoed, A.; Mulder, E. Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation. Biochemistry 1992, 31, 2393-2399.
-
(1992)
Biochemistry
, vol.31
, pp. 2393-2399
-
-
Veldscholte, J.1
Brinkman, A.O.2
Grootegoed, A.3
Mulder, E.4
-
35
-
-
0034465595
-
Dynamics of intercellular movement and nucleocyto-plasmic recycling of the ligand-activated androgen receptor in living cells
-
Tyagi, R. K.; Lavorvsky, Y.; Ahn, S. C.; Song, C. S.; Chatterjee, B. et al. Dynamics of intercellular movement and nucleocyto-plasmic recycling of the ligand-activated androgen receptor in living cells. Mol. Endocrinol. 2000, 14, 1162-1174.
-
(2000)
Mol. Endocrinol.
, vol.14
, pp. 1162-1174
-
-
Tyagi, R.K.1
Lavorvsky, Y.2
Ahn, S.C.3
Song, C.S.4
Chatterjee, B.5
-
36
-
-
0036021226
-
A phase II study of Caelyx (liposomal doxorubicin) in metastatic carcinoma of the prostate: Tolerability and efficacy modification by liposomal encapsulation
-
McMenemin, R.; Macdonald, G.; Moffat, L.; Bissett, D. A phase II study of Caelyx (liposomal doxorubicin) in metastatic carcinoma of the prostate: tolerability and efficacy modification by liposomal encapsulation. Invest. New Drugs 2002, 20, 331-337.
-
(2002)
Invest. New Drugs
, vol.20
, pp. 331-337
-
-
McMenemin, R.1
Macdonald, G.2
Moffat, L.3
Bissett, D.4
-
37
-
-
0037089475
-
CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: In vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity
-
Dubois, V.; Dasnois, L.; Ledtahi, K.; Collot, F.; Heylen, N. et al. CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity. Cancer Res. 2002, 62, 2327-2331.
-
(2002)
Cancer Res.
, vol.62
, pp. 2327-2331
-
-
Dubois, V.1
Dasnois, L.2
Ledtahi, K.3
Collot, F.4
Heylen, N.5
-
38
-
-
0035935668
-
The synthesis of a prodrug of doxorubicin to provide reduced systemic toxicity and greater target efficacy
-
Garsky, V. M.; Lumma, P. K.; Feng, D.; Wai, J.; Ramjit, H. G. et al. The synthesis of a prodrug of doxorubicin to provide reduced systemic toxicity and greater target efficacy. J. Med. Chem. 2001, 44, 4216-4224.
-
(2001)
J. Med. Chem.
, vol.44
, pp. 4216-4224
-
-
Garsky, V.M.1
Lumma, P.K.2
Feng, D.3
Wai, J.4
Ramjit, H.G.5
-
39
-
-
0035942522
-
Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands
-
Marhefka, C. A.; Moore, B. M.; Bishop, T. C.; Kirkovsky, L.; Mukherjee, A. et al. Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands. J. Med. Chem. 2001, 44, 1729-1740.
-
(2001)
J. Med. Chem.
, vol.44
, pp. 1729-1740
-
-
Marhefka, C.A.1
Moore, B.M.2
Bishop, T.C.3
Kirkovsky, L.4
Mukherjee, A.5
-
40
-
-
0025891206
-
A potential radioiodinated ligand for the androgen receptor: 7α-methyl-17α-(2′-(E)-iodovinyl)-19-nortestosterone
-
Salman, M.; Chamness, G. C. A potential radioiodinated ligand for the androgen receptor: 7α-methyl-17α-(2′ -(E)-iodovinyl)-19-nortestosterone. J. Med. Chem. 1991, 34, 1019-1024.
-
(1991)
J. Med. Chem.
, vol.34
, pp. 1019-1024
-
-
Salman, M.1
Chamness, G.C.2
-
41
-
-
0025036686
-
Synthesis and androgen receptor binding of dihydrotestosterone hemisuccinate homologues
-
Stobaugh, M. E.; Blickenstaff, R. T. Synthesis and androgen receptor binding of dihydrotestosterone hemisuccinate homologues. Steroids 1990, 55, 259-262.
-
(1990)
Steroids
, vol.55
, pp. 259-262
-
-
Stobaugh, M.E.1
Blickenstaff, R.T.2
-
42
-
-
0026355472
-
Dihydrotestosterone derivatives: Relative binding affinity versus affinity purification
-
Stobaugh, M. E.; Blickenstaff, R. T. Dihydrotestosterone derivatives: relative binding affinity versus affinity purification. Steroids 1991, 56, 581-585.
-
(1991)
Steroids
, vol.56
, pp. 581-585
-
-
Stobaugh, M.E.1
Blickenstaff, R.T.2
-
43
-
-
0034710716
-
Design, synthesis, and pharmacological characterization of 4-[4,4-dimethyl-3-(4-hydroxybutyl)-5-oxo-2-thioxo-1-imidazolidinyl] -2-iodobenzonitrile as a high-affinity nonsteroidal androgen receptor ligand
-
van Dort, M. E.; Robins, D. M.; Wayburn, B. Design, synthesis, and pharmacological characterization of 4-[4,4-dimethyl-3-(4-hydroxybutyl)-5-oxo-2-thioxo-1-imidazolidinyl] -2-iodobenzonitrile as a high-affinity nonsteroidal androgen receptor ligand. J. Med. Chem. 2000, 43, 3344-3347.
-
(2000)
J. Med. Chem.
, vol.43
, pp. 3344-3347
-
-
Van Dort, M.E.1
Robins, D.M.2
Wayburn, B.3
-
44
-
-
0035938418
-
Synthesis and structure-activity studies of side-chain derivitized arylhydantoins for investigation as androgen receptor radioligands
-
van Dort, M. E.; Jung, Y. Synthesis and structure-activity studies of side-chain derivitized arylhydantoins for investigation as androgen receptor radioligands. Bioorg. Med. Chem. Lett. 2001, 11, 1045-1047.
-
(2001)
Bioorg. Med. Chem. Lett.
, vol.11
, pp. 1045-1047
-
-
Van Dort, M.E.1
Jung, Y.2
-
45
-
-
0028347104
-
RU 58841, anew specific topical antiandrogen: A candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism
-
Battmann, T.; Bonfils, A.; Branche, C.; Humbert, J.; Goubet, F. et al. RU 58841, anew specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism. J. Steroid Biochem. Mol. Biol. 1994, 48, 55-60.
-
(1994)
J. Steroid Biochem. Mol. Biol.
, vol.48
, pp. 55-60
-
-
Battmann, T.1
Bonfils, A.2
Branche, C.3
Humbert, J.4
Goubet, F.5
-
46
-
-
0018774198
-
Action of a nonsteroidal anti-androgen, RU 23908, in peripheral and cantral tissues
-
Raynaud, J. P.; Bonne, C.; Bouton, M. M.; Lagace, L.; Labrie, F. Action of a nonsteroidal anti-androgen, RU 23908, in peripheral and cantral tissues. J. Steroid Biochem. 1979, 11, 93-99.
-
(1979)
J. Steroid Biochem.
, vol.11
, pp. 93-99
-
-
Raynaud, J.P.1
Bonne, C.2
Bouton, M.M.3
Lagace, L.4
Labrie, F.5
-
47
-
-
0021224888
-
The pure antiandrogen RU23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: A review
-
Raynaud, J. P.; Bonne, C.; Moguilewsky, M.; Lefebvre, F. A.; Belanger, A. et al. The pure antiandrogen RU23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: a review. Prostate 1984, 5, 299-311.
-
(1984)
Prostate
, vol.5
, pp. 299-311
-
-
Raynaud, J.P.1
Bonne, C.2
Moguilewsky, M.3
Lefebvre, F.A.4
Belanger, A.5
-
48
-
-
0031891812
-
Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders
-
Battmann, T.; Branche, C.; Bouchoux, F.; Cerede, E.; Philibert, D. et al. Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders. J. Steroid. Biochem. Mol. Biol. 1998, 54, 103-111.
-
(1998)
J. Steroid. Biochem. Mol. Biol.
, vol.54
, pp. 103-111
-
-
Battmann, T.1
Branche, C.2
Bouchoux, F.3
Cerede, E.4
Philibert, D.5
-
49
-
-
0024935035
-
Synthesis and antitumor activity of new amphiphilic alkylglycerolipids substituted with a polar headgroup, 2, 2(trimethylammonioethoxy)ethyl or a congeneric oilgo(ethyleneoxy)ethyl group
-
Ukawa, K.; Imamiya, E.; Yamamoto, H.; Aono, T.; Kozai, O. et al. Synthesis and antitumor activity of new amphiphilic alkylglycerolipids substituted with a polar headgroup, 2, 2(trimethylammonioethoxy)ethyl or a congeneric oilgo(ethyleneoxy)ethyl group. Chem. Pharm. Bull. 1989, 37, 3277-3285.
-
(1989)
Chem. Pharm. Bull.
, vol.37
, pp. 3277-3285
-
-
Ukawa, K.1
Imamiya, E.2
Yamamoto, H.3
Aono, T.4
Kozai, O.5
-
50
-
-
0024806556
-
Oxidation of β-blocking agents - VII. Periodate oxidation of Labetalol
-
Salomies, H.; Luukkansen, L.; Knuutila, R. Oxidation of β-blocking agents - VII. Periodate oxidation of Labetalol. J. Pharm. Biomed. 1989, 7, 1447-1451.
-
(1989)
J. Pharm. Biomed.
, vol.7
, pp. 1447-1451
-
-
Salomies, H.1
Luukkansen, L.2
Knuutila, R.3
-
51
-
-
0033551680
-
Reductive etherification of aromatic aldehydes with decaborane
-
Lee, S. H.; Park, Y. J.; Yoon, C. M. Reductive etherification of aromatic aldehydes with decaborane. Tetrahedron Lett. 1999, 40, 6049-6050.
-
(1999)
Tetrahedron Lett.
, vol.40
, pp. 6049-6050
-
-
Lee, S.H.1
Park, Y.J.2
Yoon, C.M.3
-
52
-
-
0021259911
-
β-Adrenergic blocking agents: substituted phenylalkanolamines. Effects of side-chain length on β-blocking potency in vitro
-
Fuhrer, W.; Ostermayer, F.; Zimmermann, M.; Meier, M.; Müller, H. β-Adrenergic blocking agents: substituted phenylalkanolamines. Effects of side-chain length on β-blocking potency in vitro. J. Med. Chem. 1984, 27, 831-836.
-
(1984)
J. Med. Chem.
, vol.27
, pp. 831-836
-
-
Fuhrer, W.1
Ostermayer, F.2
Zimmermann, M.3
Meier, M.4
Müller, H.5
-
53
-
-
4243869042
-
Disappearance of inter-and intramolecular stacking due to one-atom addition in 'propylene-linker' in a pyrazolo[3, 4-d]pyrimidine-based flexible molecule
-
Avasthi, K.; Farooq, S. M.; Sharon, A.; Maulik, P. R. Disappearance of inter-and intramolecular stacking due to one-atom addition in 'propylene-linker' in a pyrazolo[3, 4-d]pyrimidine-based flexible molecule. Acta Crystallogr. E 2002, E58, o940-o941.
-
(2002)
Acta Crystallogr. E
, vol.E58
-
-
Avasthi, K.1
Farooq, S.M.2
Sharon, A.3
Maulik, P.R.4
-
54
-
-
0034714276
-
Structural evidence for ligand specificity in the binding domain of the human androgen receptor
-
Matias, P. M.; Donner, P.; Coelho, R.; Thomaz, M.; Peixoto, C. et al. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. J. Biol. Chem. 2000, 275, 26164-26171.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 26164-26171
-
-
Matias, P.M.1
Donner, P.2
Coelho, R.3
Thomaz, M.4
Peixoto, C.5
-
55
-
-
0034456723
-
Androgen-induced growth inhibition of androgen receptor expressing androgen-independent prostate cancer cells is mediated by increased levels of neutral endopeptidases
-
Shen, R.; Sumitomo, M.; Dai, J.; Harris, A.; Kaminetzky, D. et al. Androgen-induced growth inhibition of androgen receptor expressing androgen-independent prostate cancer cells is mediated by increased levels of neutral endopeptidases. Endocrinology 2000, 141, 1699-1704.
-
(2000)
Endocrinology
, vol.141
, pp. 1699-1704
-
-
Shen, R.1
Sumitomo, M.2
Dai, J.3
Harris, A.4
Kaminetzky, D.5
-
56
-
-
0030248999
-
Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells
-
Dai, J. L.; Maiorino, C. A.; Gkonus, P. J.; Burnstein, K. L. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells. Steroids 1996, 61, 531-539.
-
(1996)
Steroids
, vol.61
, pp. 531-539
-
-
Dai, J.L.1
Maiorino, C.A.2
Gkonus, P.J.3
Burnstein, K.L.4
-
57
-
-
0019720284
-
Receptor binding and biological activity of steroidal and non-steroidal antiandrogens
-
Wakeling, A. E.; Furr, B. J. A.; Glen, A. T.; Hughes, L. R. Receptor binding and biological activity of steroidal and non-steroidal antiandrogens. J. Steroid Biochem. 1981, 15, 355-359.
-
(1981)
J. Steroid Biochem.
, vol.15
, pp. 355-359
-
-
Wakeling, A.E.1
Furr, B.J.A.2
Glen, A.T.3
Hughes, L.R.4
-
58
-
-
0036697795
-
Resolution of genotypic heterogeneity in prostate tumors using polymerase chain reaction and comparative genomic hybridization on microdissected carcinoma and prostatic intraepithelial neoplasia foci
-
Beheshti, B.; Vukovic, B.; Marrano, P.; Squire, J. A.; Park, P. C. Resolution of genotypic heterogeneity in prostate tumors using polymerase chain reaction and comparative genomic hybridization on microdissected carcinoma and prostatic intraepithelial neoplasia foci. Cancer Genet. CytoGen. 2002, 137, 15-22.
-
(2002)
Cancer Genet. CytoGen.
, vol.137
, pp. 15-22
-
-
Beheshti, B.1
Vukovic, B.2
Marrano, P.3
Squire, J.A.4
Park, P.C.5
-
59
-
-
0025807069
-
Effects of steroidal and nonsteroidal antiandrogens on the androgen binding properties of the rat andogen receptor
-
Steinsapir, J.; Mora, G.; Muldoon, T. G. Effects of steroidal and nonsteroidal antiandrogens on the androgen binding properties of the rat andogen receptor. BBA-Mol. Cell. Res. 1991, 1094, 103-112.
-
(1991)
BBA-Mol. Cell. Res.
, vol.1094
, pp. 103-112
-
-
Steinsapir, J.1
Mora, G.2
Muldoon, T.G.3
-
60
-
-
0021261993
-
The use of hydroxylapatite-filter steroid receptor assay method in the study of the modulation of androgen receptor interaetion
-
Liao, S.; Witte, D.; Schilling, K.; Chang, C. The use of hydroxylapatite-filter steroid receptor assay method in the study of the modulation of androgen receptor interaetion. J. Steroid Biochem. 1984, 20, 11-17.
-
(1984)
J. Steroid Biochem.
, vol.20
, pp. 11-17
-
-
Liao, S.1
Witte, D.2
Schilling, K.3
Chang, C.4
|